The US Food and Drug Administration (FDA) has approved US-based StemCells’ investigational new drug (IND) application for clinical testing of its HuCNS-SC human neural stem cells as a treatment for spinal cord injury. StemCells is ...
Tags: Spinal Cord Injury, Medicine
StemCells has obtained US Patent for its human liver engrafting cells (hLEC), under patent number 8,283,164 titled 'Liver engrafting cells, assays and uses thereof'. Researchers of the firm have demonstrated the hLEC cells engraftment and ...